MCIT holds 2nd executive roundtable to adopt Copilot in government entities
DOHA: As part of its commitment to enhancing government efficiency and adopting advanced AI tools, the Ministry of Communications and Information Technology (MCIT) held the second executive roundtable for the Copilot Adoption Program, with participation from leadership representatives across government entities.
The roundtable served as a platform to review the progress achieved since the program's launch in February, evaluate key outcomes, and explore pathways to expand and deepen Copilot's implementation in the coming phase.
The meeting featured a comprehensive overview of achievements in the first phase, including the successful delivery of over 174 specialized training sessions for representatives across government entities, with 56 additional sessions scheduled through June.
The discussions also addressed upcoming priorities, such as achieving full license activation, activating the AI Council to oversee institutional adoption, and launching internal Copilot Champions programs to support training, engagement, and expansion efforts across government organizations.
Program indicators revealed steady progress, with 67% of licenses activated and strong satisfaction scores from participating employees, 90% for content quality and 95% for training delivery.
These results reflect broad engagement from the participating entities and a growing culture of digital enablement in the public sector.
This upward trend is expected to continue as the program moves into its next stage, with more advanced workshops and expanded technical support planned in the months ahead.
At the conclusion of the meeting, MCIT honoured Sidra Medicine, Ashghal, and the ministry's internal teams in recognition of their tangible efforts to drive institutional adoption and optimize the tool's impact on productivity.
The Copilot Adoption Program, launched in February, represents one of the key pillars of the Qatar Digital Agenda 2030. It serves as a practical model of MCIT's strategic direction to leverage advanced technologies in modernizing government operations and equipping employees with cutting-edge digital tools.
The program also reflects the ministry's commitment to fostering a culture of innovation within public institutions and expanding the use of artificial intelligence across sectors, contributing to greater operational efficiency and added value in the delivery of public services.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Qatar Tribune
a day ago
- Qatar Tribune
MCIT holds 2nd executive roundtable
QNA Doha As part of its commitment to enhancing government efficiency and adopting advanced AI tools, the Ministry of Communications and Information Technology (MCIT) held the second executive roundtable for the Copilot Adoption Programme, with participation from leadership representatives across government entities. The roundtable served as a platform to review progress achieved since the programme's launch in February, evaluate key outcomes, and explore pathways to expand and deepen Copilot's implementation in the upcoming phase. The meeting featured a comprehensive overview of first-phase achievements, including the successful delivery of over 174 specialised training sessions for representatives across government entities, with 56 additional sessions scheduled through June. Discussions also addressed upcoming priorities, such as achieving full licence activation, activating the AI Council to oversee institutional adoption, and launching internal Copilot Champions programmes to support training, engagement, and expansion efforts across government organisations. Programme indicators revealed steady progress, with 67 percent of licences activated and strong satisfaction scores from participating employees—90 percent for content quality and 95 percent for training delivery. These results reflect strong engagement from participating entities and a growing culture of digital enablement within the public sector. This positive trajectory is expected to continue as the programme enters its next stage, with more advanced workshops and expanded technical support planned in the coming months. At the conclusion of the meeting, MCIT honoured Sidra Medicine, Ashghal, and its internal teams in recognition of their tangible efforts to drive institutional adoption and maximise the tool's impact on productivity. Launched in February, the Copilot Adoption Programme represents a key pillar of the Qatar Digital Agenda 2030. It serves as a practical model of MCIT's strategic direction to leverage advanced technologies in modernising government operations and equipping employees with cutting-edge digital tools. The programme also reflects the ministry's commitment to fostering a culture of innovation within public institutions and broadening the use of artificial intelligence across sectors—ultimately contributing to greater operational efficiency and added value in public service delivery.
Qatar Tribune
3 days ago
- Qatar Tribune
MCIT holds 2nd executive roundtable to adopt Copilot in government entities
DOHA: As part of its commitment to enhancing government efficiency and adopting advanced AI tools, the Ministry of Communications and Information Technology (MCIT) held the second executive roundtable for the Copilot Adoption Program, with participation from leadership representatives across government entities. The roundtable served as a platform to review the progress achieved since the program's launch in February, evaluate key outcomes, and explore pathways to expand and deepen Copilot's implementation in the coming phase. The meeting featured a comprehensive overview of achievements in the first phase, including the successful delivery of over 174 specialized training sessions for representatives across government entities, with 56 additional sessions scheduled through June. The discussions also addressed upcoming priorities, such as achieving full license activation, activating the AI Council to oversee institutional adoption, and launching internal Copilot Champions programs to support training, engagement, and expansion efforts across government organizations. Program indicators revealed steady progress, with 67% of licenses activated and strong satisfaction scores from participating employees, 90% for content quality and 95% for training delivery. These results reflect broad engagement from the participating entities and a growing culture of digital enablement in the public sector. This upward trend is expected to continue as the program moves into its next stage, with more advanced workshops and expanded technical support planned in the months ahead. At the conclusion of the meeting, MCIT honoured Sidra Medicine, Ashghal, and the ministry's internal teams in recognition of their tangible efforts to drive institutional adoption and optimize the tool's impact on productivity. The Copilot Adoption Program, launched in February, represents one of the key pillars of the Qatar Digital Agenda 2030. It serves as a practical model of MCIT's strategic direction to leverage advanced technologies in modernizing government operations and equipping employees with cutting-edge digital tools. The program also reflects the ministry's commitment to fostering a culture of innovation within public institutions and expanding the use of artificial intelligence across sectors, contributing to greater operational efficiency and added value in the delivery of public services.
ILoveQatar.net
4 days ago
- ILoveQatar.net
H.H. Sheikha Moza inaugurates Sidra Medicine's new Pediatric Hematopoietic Stem Cell Transplant Ward
Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation for Education, Science and Community Development, officially inaugurated the new pediatric Hematopoietic Stem Cell Transplant (HSCT) ward at Sidra Medicine, a Qatar Foundation entity. The new ward is dedicated to treating children with blood disorders, immune system diseases, and genetic conditions. During the visit, Her Highness toured the facility, engaged with clinical teams, and received an overview of the HSCT program's role in advancing care and stem cell and gene therapies for children in Qatar and the region. Her Highness was accompanied by His Excellency Mansoor bin Ebrahim bin Saad Al Mahmoud, the Minister of Public Health, members of Sidra Medicine's Board of Directors and senior leadership, including Dr. Iyabo Tinubu-Karch, Chief Executive Officer and Prof. Ibrahim Janahi, Chief Medical Officer. The HSCT ward is a core part of Sidra Medicine's HSCT Program, using curative therapies to provide life-saving care and treatment for children with a range of blood diseases and cancers. This includes malignant and non-malignant conditions such as leukemia, lymphoma, thalassemia, sickle cell disease, immune deficiencies, and metabolic disorders. HSCT also known as bone marrow transplant, replaces diseased or damaged bone marrow with healthy stem cells from the patient (autologous) or a donor (allogeneic). Dr. Iyabo Tinubu-Karch, CEO of Sidra Medicine, said: 'The opening of our new pediatric Hematopoietic Stem Cell Transplant Ward, the first of its kind in the country, marks a major step in expanding access to life-saving care for children in Qatar and the region. As the HSCT program grows, it will play a vital role in reducing the need for outbound referrals and in positioning Qatar as a center of excellence for pediatric cell and gene therapies. This is about building sustainable, high-quality care close to home for our patients and their families.' Prof. Ibrahim Janahi, Chief Medical Officer at Sidra Medicine, said: 'The launch of the HSCT Ward reflects our commitment to supporting the Qatar National Vision 2030. It strengthens the foundation of a knowledge-based economy by building national expertise in precision and regenerative medicine. Our goal is to ensure that every child in Qatar can access the best possible treatment, close to home and grounded in clinical excellence.' Managed by the Hematology and Oncology Division at Sidra Medicine, the new ward is designed exclusively for pediatric patients under the age of 18. It is divided into two main sections - one section for children undergoing HSCT and the other for patients with complex hematology-oncology diagnoses such as cancer, that require intensive chemotherapy and inpatient care. With an initial capacity of 20 beds, the new pediatric HSCT ward integrates cutting-edge infrastructure, including high-level isolation facilities that meet international infection control standards. It is scheduled to receive patients for autologous transplants in late June of 2025 with preparations underway to care for inpatient children who will undergo allogeneic transplants, at a later stage. Dr. Ayman Saleh, Division Chief of Pediatric Hematology-Oncology & Hematopoietic Stem Cell Transplant at Sidra Medicine said: 'Our HSCT program brings together key specialties to deliver advanced and curative care for children with complex conditions. With four autologous procedures successfully completed and plans underway to offer allogeneic transplants in the near future, we are building a strong foundation for pediatric cellular therapy in Qatar. This service is a testament to the pioneering and family-centered care and cure approach that we offer to all our patients.' In addition to treating patients with various blood diseases and cancers, the HSCT program at Sidra Medicine is the core part of its precision medicine strategy to facilitate genomic research programs for pediatric autoimmune disorders, genetic and rare diseases. Sidra Medicine's HSCT program is further enhanced by a Good Manufacturing Practice (GMP)-qualified laboratory team operating under the Advanced Cell Therapy Core (ACTC). The ACTC manages the processing and cryopreservation of hematopoietic stem cells and is currently working toward Sidra Medicine's qualification as a treatment center for Casgevy, a gene therapy for thalassemia and sickle cell disease. Dr. Chiara Cugno, Director of the Advanced Cell Therapy Core and GMP Facility at Sidra Medicine said: 'Our GMP-qualified laboratory is a key enabler in delivering safe and effective cellular therapies. By maintaining the highest standards in cell processing and cryopreservation, we are supporting precision treatments for children with cancer, blood, and immunologic disorders. It is an essential part of ensuring every child receives the most personalized care possible.' All HSCT program services will be open to both local and international patients, with more than 50 children currently awaiting transplantation in Qatar. Future phases for the HSCT program include scaling allogeneic transplant capacity and introducing CAR-T cell and gene therapies. The HSCT program includes a multidisciplinary team of specialized physicians, apheresis-trained staff, dedicated HSCT nurses, and allied health professionals. The Sidra Medicine care team also involves experts in immunology, infectious diseases, radiology, psychology, pharmacy, nutrition, child life, and social work. The integrated approach ensures comprehensive and patient-centered care throughout the transplant journey. Before a transplant, every child will go through a detailed evaluation at Sidra Medicine's outpatient clinic to ensure they are ready for the procedure. Once admitted, the children will undergo conditioning chemotherapy to prepare their bodies for the stem cell infusion. They will then be monitored very closely during the aplasia phase, when their immune system is at its weakest. Most patients will stay at the hospital for about 30 to 40 days. Following discharge, they will continue their care through regular follow-ups in an outpatient setting. In addition to medical and nursing care, Sidra Medicine offers support services for patients and families, including social work, clinical nurse specialists, and case management. While formal support groups are under development, ongoing engagement with families is embedded throughout the care process. For more details about Sidra Medicine's Hematology and Oncology services and its GMP facility, please visit:
